Saturday, September 26, 2020

CSIR and Aurobindo Pharma collaborates to develop COVID-19 vaccine

Must Read

How did Namrata Shirodkar, Mahesh Babu react to drug controversy?

Hyderabad: After many a few A-listers names including Deepika Padukone, Sara Ali Khan, Shraddha Kapoor and Rakul Preet Singh...

KTR holds video conference to resolve revenue problems

Hyderabad: Municipal Administration and Urban Development Minister K Tarakarama Rao on Saturday held a video conference to sort out...

Speeding truck crashes into Tarnaka flyover in the city Today

First level flyover at Biodiversity Junction in Hyderabad. Photo: Mohammed Hussain Sakina Fatima Hyderabad: Early Morning a speeding container the truck...

Hyderabad: The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limitedare on Tuesday announced its collaboration to develop vaccines against SARS-CoV-2 (COVID-19) . Under the signed agreement between CSIR-Centre for Cellular and Molecular Biology (CCMB) and Aurobindo Pharma, the latter will partner with CSIR for development of several novel COVID-19 vaccines. 

Three CSIR labs namely CCMB Hyderabad, Institute of Medical Technology (IMTECH), Chandigarh and Indian Institute of Chemical Biology (IICB), Kolkata, are developing vaccine candidates using different technology platforms. Aurobindo will undertake clinical development and commercialization of the vaccines.

Commenting on this partnership, Dr Shekhar C Mande,Director General, CSIR, said that “Joining of hands of premier CSIR labs with industry for development of vaccines will amplify India’s efforts in indigenous vaccine development and also help in preparedness for future pandemics”. 

Commenting on the development strategies for the vaccines, Dr. Rakesh Mishra, Director, CSIR-CCMB said,“Our labs are working on novel proteins for vaccine development that have the potential to address the need for a second-generation vaccine. We are happy to partner with Aurobindo who have proven manufacturing and commercialization capabilities”

“We are proud to join hands with CSIR for developing vaccines to combat the COVID-19 pandemic. This collaboration further strengthens our COVID-19 vaccine development efforts. We are already setting up a large-scale facility in Hyderabad for manufacturing COVID-19 vaccine and other viral vaccines,” said N. Govindarajan, Managing Director, Aurobindo Pharma Limited. 

Subscribe us on The Siasat Daily - Google NewsThe Siasat Daily - Google News

Latest News

How did Namrata Shirodkar, Mahesh Babu react to drug controversy?

Hyderabad: After many a few A-listers names including Deepika Padukone, Sara Ali Khan, Shraddha...

KTR holds video conference to resolve revenue problems

Hyderabad: Municipal Administration and Urban Development Minister K Tarakarama Rao on Saturday held a video conference to sort out various revenue related problems under...

Speeding truck crashes into Tarnaka flyover in the city Today

First level flyover at Biodiversity Junction in Hyderabad. Photo: Mohammed Hussain Sakina Fatima Hyderabad: Early Morning a speeding container the truck crashed into the Tarnaka flyover...

NCB arrests producer Kshitij Ravi Prasad in drug case

Mumbai: The Narcotics Control Bureau (NCB) on Saturday arrested Dharma Productions executive producer Kshitij Ravi Prasad in connection with a drug case related to actor Sushant Singh Rajput’s...

NIMS gets new machine for COVID-19 tests

Hyderabad: The Nizam’s Institute of Medical Sciences (NIMS) on Friday became the first hospital in South India to install and operationalize Cobas-8800 RT-PCR. The new machine...

More Articles Like This